DiaMedica Therapeutics Inc. (DMAC): Price and Financial Metrics

DiaMedica Therapeutics Inc. (DMAC): $4.26

0.05 (-1.16%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add DMAC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#130 of 332

in industry

DMAC Price/Volume Stats

Current price $4.26 52-week high $4.95
Prev. close $4.31 52-week low $2.12
Day low $4.23 Volume 59,600
Day high $4.39 Avg. volume 49,830
50-day MA $4.29 Dividend yield N/A
200-day MA $3.35 Market Cap 182.11M

DMAC Stock Price Chart Interactive Chart >


DiaMedica Therapeutics Inc. (DMAC) Company Bio


DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.


DMAC Latest News Stream


Event/Time News Detail
Loading, please wait...

DMAC Latest Social Stream


Loading social stream, please wait...

View Full DMAC Social Stream

DMAC Price Returns

1-mo -4.27%
3-mo 18.33%
6-mo 34.38%
1-year 73.88%
3-year 5.71%
5-year 20.34%
YTD 50.00%
2023 79.74%
2022 -57.64%
2021 -63.21%
2020 109.07%
2019 66.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!